Skip to main content
Journal cover image

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update.

Publication ,  Journal Article
Wilson, S; Anderson, K; Baldwin, D; Dijk, D-J; Espie, A; Espie, C; Gringras, P; Krystal, A; Nutt, D; Selsick, H; Sharpley, A
Published in: J Psychopharmacol
August 2019

This British Association for Psychopharmacology guideline replaces the original version published in 2010, and contains updated information and recommendations. A consensus meeting was held in London in October 2017 attended by recognised experts and advocates in the field. They were asked to provide a review of the literature and identification of the standard of evidence in their area, with an emphasis on meta-analyses, systematic reviews and randomised controlled trials where available, plus updates on current clinical practice. Each presentation was followed by discussion, aiming to reach consensus where the evidence and/or clinical experience was considered adequate, or otherwise to flag the area as a direction for future research. A draft of the proceedings was circulated to all speakers for comments, which were incorporated into the final statement.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Psychopharmacol

DOI

EISSN

1461-7285

Publication Date

August 2019

Volume

33

Issue

8

Start / End Page

923 / 947

Location

United States

Related Subject Headings

  • Sleep Initiation and Maintenance Disorders
  • Randomized Controlled Trials as Topic
  • Psychopharmacology
  • Psychiatry
  • Parasomnias
  • London
  • Humans
  • Evidence-Based Medicine
  • Consensus
  • Chronobiology Disorders
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wilson, S., Anderson, K., Baldwin, D., Dijk, D.-J., Espie, A., Espie, C., … Sharpley, A. (2019). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J Psychopharmacol, 33(8), 923–947. https://doi.org/10.1177/0269881119855343
Wilson, Sue, Kirstie Anderson, David Baldwin, Derk-Jan Dijk, Audrey Espie, Colin Espie, Paul Gringras, et al. “British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update.J Psychopharmacol 33, no. 8 (August 2019): 923–47. https://doi.org/10.1177/0269881119855343.
Wilson S, Anderson K, Baldwin D, Dijk D-J, Espie A, Espie C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J Psychopharmacol. 2019 Aug;33(8):923–47.
Wilson, Sue, et al. “British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update.J Psychopharmacol, vol. 33, no. 8, Aug. 2019, pp. 923–47. Pubmed, doi:10.1177/0269881119855343.
Wilson S, Anderson K, Baldwin D, Dijk D-J, Espie A, Espie C, Gringras P, Krystal A, Nutt D, Selsick H, Sharpley A. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J Psychopharmacol. 2019 Aug;33(8):923–947.
Journal cover image

Published In

J Psychopharmacol

DOI

EISSN

1461-7285

Publication Date

August 2019

Volume

33

Issue

8

Start / End Page

923 / 947

Location

United States

Related Subject Headings

  • Sleep Initiation and Maintenance Disorders
  • Randomized Controlled Trials as Topic
  • Psychopharmacology
  • Psychiatry
  • Parasomnias
  • London
  • Humans
  • Evidence-Based Medicine
  • Consensus
  • Chronobiology Disorders